DIGITAL AGE: THE IMPORTANCE OF 21ST CENTURY SKILLS AMONG THE UNDERGRADUATES



Colchicine in patients with heart failure and preserved left ventricular ejection fraction: rationale and design of a prospective, randomised, open-label, crossover clinical trial

Introduction Systemic low-grade inflammation is a fundamental pathophysiological mechanism of heart failure with preserved left ventricular ejection fraction (HFpEF).The efficacy of anti-inflammatory therapy in HFpEF is largely understudied.The aim of the study is to assess the anti-inflammatory effect of colchicine in HFpEF by looking at inflammat

read more